Oncology

With the peak of summer approaching, Vanderbilt researchers will discuss innovative research on melanoma and how new insights could lead to less toxic treatments and better outcomes for patients. “Toward a Cure for Melanoma” will take place on Tuesday, July 27, at noon CT. Read More

Dr. Levi Garraway, senior vice president for global development and medical affairs for Lilly Oncology, will present the 16th annual Levi Watkins Jr., M.D., Lecture Oct. 10. Read More

Vanderbilt University Medical Center (VUMC) has been named to the 2016 Becker’s Hospital Review list of 100 Hospitals and Health Systems with Great Oncology Programs. The annual list recognizes organizations leading the nation in cancer care. Read More

1,165 budding programmers are participating in the university’s first MOOC capstone project – one that will result in a certificate for graduates and better pain management for patients at Vanderbilt University Medical Center. Read More

Patrick Grohar came to Vanderbilt in January from the National Cancer Institute, bringing with him his passions and self-motivation for lab-based work. His research focuses on drug discovery in pediatric sarcomas, cancers that develop in bone and soft tissues. Read More

With the peak of summer approaching, Vanderbilt researchers will discuss innovative research on melanoma and how new insights could lead to less toxic treatments and better outcomes for patients. The discussion is part of the School of Medicine Basic Sciences’ monthly Lab-to-Table Conversation series. The event “Toward… Read More

With the peak of summer approaching, Vanderbilt researchers will discuss innovative research on melanoma and how new insights could lead to less toxic treatments and better outcomes for patients. The discussion is part of the School of Medicine Basic Sciences’ monthly Lab-to-Table Conversation series. The event “Toward… Read More

A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies. Read More

New details on the DNA-cutting activity of topoisomerase II, a target of anti-cancer drugs, could lead to better chemotherapeutic agents. Read More

Investigators from Vanderbilt-Ingram Cancer Center and 12 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled median overall survival. Read More

Providing increased mentorship, research opportunities and a nurturing, intellectual environment during fellowship training may help reduce a projected shortage of academic hematologists and oncologists. Read More

Helicobacter pylori, a bacterium that infects half of the world’s population and increases the risk for stomach cancer, appears to impair nutrient absorption. Read More

Blocking a certain protein during radiation to treat brain cancers could protect the brain’s thinking powers. Read More

Art, food, culture and adventure await you on Vanderbilt's campus. Read More